Arrowstreet Capital, Limited Partnership Innoviva, Inc. Transaction History

Arrowstreet Capital, Limited Partnership

  • $108 Billion
  • Q1 2024

A detailed history of Arrowstreet Capital, Limited Partnership transactions in Innoviva, Inc. stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 464,037 shares of INVA stock, worth $7.61 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
464,037
Previous 232,219 99.83%
Holding current value
$7.61 Million
Previous $3.73 Million 89.85%
% of portfolio
0.01%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$14.56 - $16.78 $3.38 Million - $3.89 Million
231,818 Added 99.83%
464,037 $7.07 Million
Q4 2023

Feb 14, 2024
BUY
$12.32 - $16.27 $1.41 Million - $1.86 Million
114,504 Added 97.27%
232,219 $3.73 Million
Q3 2023

Nov 14, 2023
SELL
$12.37 - $13.89 $800,326 - $898,669
-64,699 Reduced 35.47%
117,715 $1.53 Million
Q2 2023

Aug 14, 2023
BUY
$11.39 - $13.72 $2.08 Million - $2.5 Million
182,414 New
182,414 $2.32 Million
Q4 2022

Feb 14, 2023
BUY
$11.8 - $13.78 $1.39 Million - $1.63 Million
118,130 New
118,130 $1.57 Million
Q2 2022

Aug 15, 2022
SELL
$14.32 - $19.88 $16.3 Million - $22.7 Million
-1,140,778 Reduced 74.68%
386,829 $5.71 Million
Q1 2022

May 13, 2022
SELL
$15.39 - $20.25 $854,406 - $1.12 Million
-55,517 Reduced 3.51%
1,527,607 $29.6 Million
Q4 2021

Feb 14, 2022
BUY
$15.91 - $18.72 $2.61 Million - $3.07 Million
163,996 Added 11.56%
1,583,124 $27.3 Million
Q3 2021

Nov 12, 2021
BUY
$13.06 - $17.24 $9.47 Million - $12.5 Million
725,120 Added 104.48%
1,419,128 $23.7 Million
Q2 2021

Aug 13, 2021
SELL
$11.45 - $13.96 $3.84 Million - $4.68 Million
-334,937 Reduced 32.55%
694,008 $9.31 Million
Q1 2021

May 14, 2021
SELL
$11.06 - $12.87 $5.84 Million - $6.79 Million
-527,700 Reduced 33.9%
1,028,945 $12.3 Million
Q3 2020

Nov 12, 2020
SELL
$10.33 - $14.49 $80,574 - $113,022
-7,800 Reduced 0.5%
1,556,645 $16.3 Million
Q2 2020

Aug 12, 2020
SELL
$11.49 - $15.26 $29,874 - $39,676
-2,600 Reduced 0.17%
1,564,445 $21.9 Million
Q1 2020

May 15, 2020
BUY
$8.11 - $15.23 $684,167 - $1.28 Million
84,361 Added 5.69%
1,567,045 $18.4 Million
Q4 2019

Feb 13, 2020
BUY
$10.28 - $14.38 $11.3 Million - $15.8 Million
1,098,054 Added 285.48%
1,482,684 $21 Million
Q3 2019

Nov 14, 2019
SELL
$10.05 - $14.55 $4.14 Million - $6 Million
-412,215 Reduced 51.73%
384,630 $4.05 Million
Q2 2019

Aug 14, 2019
SELL
$13.1 - $14.95 $1.35 Million - $1.54 Million
-103,201 Reduced 11.47%
796,845 $11.6 Million
Q1 2019

May 15, 2019
BUY
$13.69 - $20.06 $7.51 Million - $11 Million
548,770 Added 156.22%
900,046 $12.6 Million
Q4 2018

Feb 14, 2019
BUY
$13.96 - $18.26 $1.74 Million - $2.27 Million
124,384 Added 54.82%
351,276 $6.13 Million
Q3 2018

Nov 14, 2018
SELL
$13.63 - $15.7 $8.45 Million - $9.73 Million
-619,738 Reduced 73.2%
226,892 $3.46 Million
Q2 2018

Aug 14, 2018
BUY
$13.44 - $17.59 $7.57 Million - $9.91 Million
563,140 Added 198.65%
846,630 $11.7 Million
Q1 2018

May 14, 2018
BUY
$13.8 - $16.99 $3.91 Million - $4.82 Million
283,490 New
283,490 $4.73 Million
Q4 2017

Feb 09, 2018
SELL
$11.73 - $14.75 $401,166 - $504,450
-34,200 Closed
0 $0
Q3 2017

Nov 14, 2017
BUY
$12.06 - $14.12 $412,452 - $482,904
34,200
34,200 $483,000

Others Institutions Holding INVA

# of Institutions
220
Shares Held
78.8M
Call Options Held
45.9K
Put Options Held
14.1K
View Full List

About Innoviva, Inc.

INVA Quotes by TradingView
  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.14B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Arrowstreet Capital, Limited Partnership Portfolio

Follow Arrowstreet Capital, Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email